Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tzamal Bio-Pharma is a prominent Israeli pharmaceutical company and a subsidiary of the Tzamal Medical Group, specializing in the commercialization of specialty pharmaceuticals and biotechnologies. The company serves as a strategic partner for international pharmaceutical manufacturers, managing the importation, registration, marketing, and distribution of innovative drugs and orphan treatments in Israel. Its portfolio spans diverse therapeutic areas, including oncology, cardiology, gynecology, and hematology, catering to both hospital and community healthcare sectors. Tzamal Bio-Pharma also maintains a significant presence in the generic and biosimilar markets, leveraging its extensive local expertise to navigate the Israeli regulatory landscape. Through its parent group, the company is also involved in supporting medical technology innovation and startup growth.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tzamal Bio-Pharma.